alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
§ 592.650 Inspection. Examinations of the ingredients, processing, and the product shall be made to ensure the production of a wholesome, unadulterated, and properly labeled product. Such examinations include, but are not being limited to: ( a ) Sanitation checks of plant premises, facilities, equipment, and processing operations.
( b ) Checks on ingredients and additives used in products to ensure that they are not adulterated, are fit for use as human food, and are stored, handled, and used in a sanitary manner.
( c ) Examination of the eggs or egg products used in the products to ensure they are wholesome, not adulterated, and comply with the temperature, pasteurization, or other applicable requirements.
( d ) Inspection during the processing and production of the product to determine compliance with any applicable standard or specification for such product.
( e ) Examination during processing of the product to ensure compliance with approved formulas and labeling.
( f ) Test weighing and organoleptic examinations of finished product.
# C_2010221EN.01005402.xml

| 14.8.2010 | EN | Official Journal of the European Union | C 221/54 |
| --- | --- | --- | --- |

14.8.2010

EN

Official Journal of the European Union

C 221/54

---

Action brought on 8 June 2010 — Conceria Kara v OHIM (KARA)

(Case T-270/10)

()

2010/C 221/87

Language in which the application was lodged: Italian

Parties

Parties

Applicant: Conceria Kara Srl (Trezzano sul Naviglio, Italy) (represented by: P. Picciolini, lawyer)

Applicant:

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs)

Defendant:

Other party/parties to the proceedings before the Board of Appeal of OHIM: Dima — Gida Tekstil Deri Insaat Maden Turizm Orman Urünleri Sanayi Ve Ticaret Ltd Sti

Other party/parties to the proceedings before the Board of Appeal of OHIM:

Form of order sought

Form of order sought

| — | Annulment of the decision of the Second Board of Appeal of 29 March 2010 on the appeal against the decision of the Opposition Division in Case B 1171453 in proceedings brought by Conceria Kara rejecting Community trade mark application No 5346457. |
| --- | --- |

—

Annulment of the decision of the Second Board of Appeal of 29 March 2010 on the appeal against the decision of the Opposition Division in Case B 1171453 in proceedings brought by Conceria Kara rejecting Community trade mark application No 5346457.

Pleas in law and main arguments

Pleas in law and main arguments

Applicant for a Community trade mark: DIMA — TEKSTIL DERI INSAAT MADEM TURIZM ORMAN URÜNLERE SANAYI VE TICARET LTD. STI.

Applicant for a Community trade mark:

Community trade mark concerned: Word mark ‘KARRA’ for goods and services in Classes 3, 9, 18, 20, 24, 25 and 35.

Community trade mark concerned:

Proprietor of the mark or sign cited in the opposition proceedings: The applicant.

Proprietor of the mark or sign cited in the opposition proceedings:

Mark or sign cited in opposition: Italian figurative marks ‘KARA’ (No 765 532, for goods in Class 35, and No 761 972 for goods and services in Classes 18 and 25), Community figurative trade mark No 887 810 (‘KARA’) for goods in, inter alia, Classes 18 and 25, and the business name of the Italian company ‘CONCERIA KARA S.R.L.’, the right to the use of which is claimed in relation to the same goods and services for earlier marks.

Mark or sign cited in opposition:

Decision of the Opposition Division: The opposition was upheld in part.

Decision of the Opposition Division:

Decision of the Board of Appeal: The appeal was dismissed.

Decision of the Board of Appeal:

Pleas in law: Failure to state reasons and misinterpretation and misapplication of Article 8(1)(b) of Regulation No 207/2009.

Pleas in law:

---
SERVED JULY 8, 2010 

U.S. DEPARTMENT OF TRANSPORTATION 

OFFICE OF HEARINGS 

WASHINGTON, DC 

IN THE MATTER OF 

Texas Army National Guard 

FAA DOCKET No. CP09SO0014 

(Civil Penalty Action) 

DMS No. FAA-2009-1045 

ORDER GRANTING IN PART AND DENYING IN PART 

MOTION FOR DECISION 

Complainant Federal Aviation Administration ("Complainant") has filed a Motion for 

Decision ("Motion"). In support it states that Respondent, the Texas Army National 

Guard ("Respondent"), has admitted the allegations of the Complaint, as amended.' 

Complainant also argues that its proposed civil penalty is justified and proper. 

Respondent's answer acknowledges liability. The answer also opposes Complainant's 

proposed civil penalty. Respondent asserts that the assessment proposed fails to account 

for factors relevant to the formulation of the civil penalty amount, is unwarranted, and 

should be rejected. 

Since no controversy exists concerning the substantive allegations of the Complaint, 

Complainant's Motion is granted to that extent. The Motion is denied as to penalty. The 

basis for and amount of Complainant's proposed assessment is controverted and cannot 

be resolved on the pleadings. 

' This case was originally captioned "Executive Office of the State of Texas." At Respondent's request 

{see Respondent's Answer), and with the acquiescence of Complainant (see Amended Complaint of 

Complainant), it was changed to the current caption. 
The hearing thus will be limited to the issue of penalty. It will be scheduled by 

subsequent order. 

SO ORDERED. 

T 

C. 

Richard C. Goodwin 

U.S. Administrative Law Judge 

Attachment - Service List 
FAA Docket No. CP09SO0014 

(Civil Penalty Action) 

SERVICE LIST 

ORIGINAL & ONE COPY 

Federal Aviation Administration 

800 Independence Avenue, S.W. 

Washington, DC 20591 

Attention: Hearing Docket Clerk, AGC-430 

Wilbur Wright Building—Suite 2W1000' 

ONE COPY 

Michael C. Crowley, Respondent's Counsel 

Environmental Protection & Administrative 

Law Division 

P.O. Box 12548 

Austin, TX 78711 

TEL: 512-475-4202 

FAX: 512-474-1062 

Gerald A. Ellis, Complainant's Counsel 

Southern Region, ASO-7 

Federal Aviation Administration 

P.O. Box 20636 

Atlanta, GA 30320 

TEL: 404-305-5200 

FAX: 404-305-5223 

The Honorable Richard C. Goodwin, Administrative Law Judge 

Office of Hearings, M-20 

1200 New Jersey Avenue, S.E. 

East Building Ground Floor 

RoomE12-320 

Washington, DC 20590 

TEL: Attorney-Advisor 202-366-2139 

Legal Assistant 202-366-5121 

FAX: 202 366-7536 

Service was by U.S. Mail. For service m person or by expedited courier, use the following address: Federal 

Aviation Administration, 600 Independence Avenue, S.W., Wilbur Wright Building—Suite 2W1000, Washington, 

DC 20591; Attention: Hearing Docket Clerk, AGC-430.
UNITED STATES


SECURITIES AND EXCHANGE COMMISSION


Washington, D.C. 20549





FORM 8-K





CURRENT REPORT


Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934





Date of Report (Date of earliest event reported)February 17, 2011





Progenics Pharmaceuticals, Inc.


(Exact name of registrant as specified in its charter)





Delaware

000-23143

13-3379479(State or other jurisdiction

of incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)777 Old Saw Mill River Road, Tarrytown, New York

10591(Address of principal executive offices)

(Zip Code)Registrant's telephone number, including area code (914) 789-2800





Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (seeGeneral Instruction A.2. below):








oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)





oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)




oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
  oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))










Item 8.01.  Other Events.





On February 17, 2011, Progenics reported positive preliminary data from an ongoing phase 1 study of PSMA ADC, an antibody-drug conjugate designed to selectively deliver chemotherapy to cells that express prostate-specific membrane antigen, a validated biomarker of prostate cancer. Findings were presented at the 2011 Genitourinary Cancers Symposium, a meeting co-sponsored by the American Society of Clinical Oncology (ASCO), the American Society for Radiation Oncology (ASTRO) and the Society of Urologic Oncology (SUO).





A copy of Progenics’ press release is included in this Report as Exhibit 99.1 and the information contained therein is incorporated into this Item 8.01 by this reference.





Item 9.01.  Financial Statements and Exhibits.





(d) Exhibits





Exhibit No.     Description





99.1
Press Release dated February 17, 2011.




















SIGNATURES








Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.








PROGENICS PHARMACEUTICALS, INC.


By:/s/ ROBERT A. MCKINNEY


Robert A. McKinney


Chief Financial Officer, Senior Vice President,


Finance & Operations and Treasurer











Date:  February 17, 2011
#### The People of the State of New York, Respondent, v. Herman Kronenberg, Appellant.

Judgment of the Court of Special Sessions affirmed. No opinion. Woodward, Jenks, Gaynor, Rich and Miller, JJ., concurred,
1 Ogulei, David

From: **Andrea Geiger <andreag@cooperenvironmental.com>**
Sent: **Wednesday, July 10, 2013 3:09 PM**
To: **Ogulei, David** Subject: **Information request update**

Hello David,

I just wanted to contact you to let you know that I have not forgotten your information requests, but there has been a delay in my ability to respond. We have had international visitors every day since I returned f rom AWMA, which hasn’t left me any time to gather docum ent, etc. It is still on my high priority list, an d I hope to have something to you soon.

We have been discussing strategies for getting a st ack demonstration unit up and running, which I beli eve will be very helpful for any current or future consent d ecrees or other enforcement actions. I will let you know how we progress on that score.

I do have a question – as we discussed when we met in Chicago, there are differences, albeit slight, b etween the ambient and stack Xact models. Are you interested i n a list of all Xacts that exist around the world, or just the
stack models? I could provide both, if that would be helpful. I t hink my main concern is that there simply aren’t that many stack units in existence, despite the fac t that we have proven the technology works. As we d iscussed, when there is no regulatory requirement, most indus try won’t have any interest in installing a system that has the potential to identify an emissions problem. Onc e a problem is identified, they would be obligated to fix it, which costs money – so it’s obviously easier and le ss expensive to remain ignorant. It’s an understand able position. I worry that the list of stack units we h ave sold will not provide what you might need for y our objectives. I could also provide a list of ambient units. There are a few differences, and certainly t he
environmental conditions for a stack unit are much harsher than for an ambient unit, but the overall t echnology is exactly the same. I am just trying to find out i f a list of the ambient units in addition to the st ack units would be helpful for you to justify the requirement for t he HWI in question.

I promise I will be in touch as soon as possible to provide the documents and information you requeste d. If you think of anything else, please let me know. I trul y apologize for the delay.

Best Regards, Andrea Geiger Director of Sales and Marketing/Environmental Scien tist Cooper Environmental Services, LLC 10180 SW Nimbus Ave, Suite J6 Portland, OR 97223 503-670-8127, ext 0 andreag@cooperenvironmental.com www.cooperenvironmental.com Innovation in Monitoring

Confidentiality Notice: This e-mail and any attachm ents may contain confidential information intended solely for the use of the addressee. If the reader of this message is not th e intended recipient, any distribution, copying, or use of this e-mail or its attachments is prohibited. If you received this message in err or, please notify the sender immediately by e-mail and delete this message and any copies. Thank you.
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               MAR-31-2000
<CASH>                                          84,395
<SECURITIES>                                         0
<RECEIVABLES>                                  235,218
<ALLOWANCES>                                   (6,965)
<INVENTORY>                                    157,170
<CURRENT-ASSETS>                               519,694
<PP&E>                                         677,287
<DEPRECIATION>                               (282,908)
<TOTAL-ASSETS>                               1,265,313
<CURRENT-LIABILITIES>                          295,211
<BONDS>                                              0
<PREFERRED-MANDATORY>                           42,421
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                    (41,604)
<TOTAL-LIABILITY-AND-EQUITY>                 1,265,313
<SALES>                                        384,584
<TOTAL-REVENUES>                               384,584
<CGS>                                          303,274
<TOTAL-COSTS>                                  303,274
<OTHER-EXPENSES>                               179,957<F1>
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              39,562
<INCOME-PRETAX>                              (138,209)
<INCOME-TAX>                                   (7,500)
<INCOME-CONTINUING>                          (130,709)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                 31,196
<CHANGES>                                            0
<NET-INCOME>                                 (161,905)
<EPS-BASIC>                                          0
<EPS-DILUTED>                                        0
<FN>
<F1>INCLUDES $104,351 RELATED TO ONE-TIME NON-CASH COMPENSATION EXPENSE CHARGES.
</FN>


</TABLE>
<TABLE> <S> <C>

<ARTICLE>                                          5
<MULTIPLIER>                                       1
<CURRENCY>                                         U.S. DOLLARS

<S>                                                <C>
<PERIOD-TYPE>                                      6-MOS
<FISCAL-YEAR-END>                                  DEC-31-2000
<PERIOD-START>                                     JAN-01-2000
<PERIOD-END>                                       JUN-30-2000
<EXCHANGE-RATE>                                    1
<CASH>                                                 226,984
<SECURITIES>                                           770,500
<RECEIVABLES>                                          714,862
<ALLOWANCES>                                                 0
<INVENTORY>                                          5,789,733
<CURRENT-ASSETS>                                     6,970,374
<PP&E>                                               1,700,041
<DEPRECIATION>                                      (1,011,666)
<TOTAL-ASSETS>                                      10,238,489
<CURRENT-LIABILITIES>                                3,201,824
<BONDS>                                                      0
<PREFERRED-MANDATORY>                                        0
<PREFERRED>                                                  0
<COMMON>                                             3,521,593
<OTHER-SE>                                             983,615
<TOTAL-LIABILITY-AND-EQUITY>                        10,238,489
<SALES>                                              4,256,087
<TOTAL-REVENUES>                                     4,256,087
<CGS>                                                3,306,532
<TOTAL-COSTS>                                        3,306,532
<OTHER-EXPENSES>                                       839,404
<LOSS-PROVISION>                                             0
<INTEREST-EXPENSE>                                      55,039
<INCOME-PRETAX>                                        113,049
<INCOME-TAX>                                                 0
<INCOME-CONTINUING>                                    113,049
<DISCONTINUED>                                               0
<EXTRAORDINARY>                                              0
<CHANGES>                                                    0
<NET-INCOME>                                           113,049
<EPS-BASIC>                                               0.02
<EPS-DILUTED>                                             0.02



</TABLE>
<PAGE>   1
                                                                    EXHIBIT 23.1


                        CONSENT OF INDEPENDENT AUDITORS


We consent to the incorporation by reference in (1) the Registration Statement
(Form S-8 No. 33-83442) pertaining to the Hugoton Energy Corporation 1993 Stock
Option Plan, Hugoton Energy Corporation 1993 Nonemployee Directors Stock Option
Plan, John T. McNabb, II Nonstatutory Stock Option Agreement, and David S.
Elkouri Nonstatutory Stock Option Agreement, (2) the Registration Statement
(Form S-8 No. 33-97092) pertaining to the Hugoton Energy Corporation 1995 Stock
Option Plan, (3) the Registration Statement (Form S-8 No. 33-83440) pertaining
to the Hugoton Energy Corporation 401(k) Profit Sharing Plan, (4) the
Registration Statement (Form S-8 No. 333-15095) pertaining to the Hugoton
Energy Corporation Amended and Restated 1993 Nonemployee Directors Stock Option
Plan and the Jay W. Decker Nonstatutory Stock Option Agreement and (5) the
Registration Statement (Form S-8 No. 333-36269) pertaining to the Hugoton
Energy Corporation Amended and Restated 1995 Stock Option Plan and Jay W.
Decker Nonstatutory Stock Option Agreement of our report dated March 24, 1998,
with respect to the consolidated financial statements and schedule of Hugoton
Energy Corporation included in the Annual Report (Form 10-K) for the year ended
December 31, 1997.

                                        ERNST & YOUNG LLP

Wichita, Kansas
March 24, 1998
1 talktheyhearyou.samhsa.gov | www.samhsa.gov/hable-ellos-escuchan

Las investigaciones sugieren que uno de

los factores más importantes para un

desarrollo infantil saludable es una relación

fuerte y abierta con los padres. Es

importante empezar a hablar con sus hijos

sobre el alcohol y otras drogas antes de

que estén expuestos a ellas: a partir de los

9 años.

 Ponga de manifiesto que 

usted no aprueba el 

consumo de alcohol y el 

abuso de drogas por parte 

de los menores.

Más del 80% de los jóvenes entre las

edades de 10 a 18 años dicen que sus

padres son la influencia principal en

decidir si beben. Envíe un mensaje claro y

contundente de que desaprueba el

consumo de alcohol y el uso o abuso de

otras drogas por parte de los menores.

Demuestre que se preocupa 

por la salud, el bienestar y el 

éxito de su hijo.

Los jóvenes están más dispuestos a escuchar 

cuando saben que usted está de su lado. 

Refuerce el motivo por el que no quiere que 

su hijo beba o consuma otras 

drogas: porque quiere que 

sea feliz y esté seguro. La 

conversación irá mucho mejor 

si usted es sincero y muestra 

preocupación.

Demuestre que usted es una 

buena fuente de información 

sobre el alcohol y otras drogas.

Usted quiere que su hijo tome decisiones

fundadas acerca del alcohol y otras drogas

con información fiable sobre sus peligros.

Usted no desea que su hijo aprenda sobre

el alcohol y otras drogas de fuentes poco

fiables. Establézcase como una fuente de

información digna de confianza.

Hable con los niños sobre el alcohol y 

otras drogas: 5 objetivos de conversación
2 talktheyhearyou.samhsa.gov | www.samhsa.gov/hable-ellos-escuchan

Muestre que presta 

atención y así desalentará 

los comportamientos 

arriesgados.

Muestre que está al tanto de lo que hace su 

hijo, ya que es más probable que los jóvenes 

beban o consuman otras drogas si creen que 

nadie se dará cuenta. Hágalo de forma sutil, 

sin entrometerse.

Fomente las habilidades y 

estrategias de su hijo para 

que evite el consumo de 

alcohol y drogas.

Aun si usted no cree que su hijo quiera beber 

o probar otras drogas, la presión de los 

compañeros es algo muy poderoso. Tener 

un plan para evitar el consumo de alcohol 

y drogas puede ayudar a los niños a tomar 

mejores decisiones. Hable con su hijo sobre 

lo que haría si se enfrentara a una decisión 

sobre el alcohol y las drogas, tal como enviar 

un mensaje de texto con una palabra clave 

a un miembro de la familia o practicar cómo 

dirá “no, gracias”. 

Manténgalo sencillo. No se preocupe, no 

tiene que comunicar todo en una sola charla. 

Planifique tener muchas charlas breves.
<PAGE>
 
                                                                   EXHIBIT 23.2
 
                      CONSENT OF INDEPENDENT ACCOUNTANTS
 
The Board of Directors
CCC Information Services Group Inc.
     
  We hereby consent to the incorporation by reference in the Prospectus
constituting part of the Registration Statement on Form S-3 (No. 33-93544) of
White River Corporation of our report dated January 21, 1998 except as to Note
15 which is as of February 10, 1998, relating to the consolidated financial
statements of CCC Information Services Group Inc. (a subsidiary of White River
Corporation) and its Subsidiaries which report appears on page F-28 of White
River Corporation's Form 10-K/A for the year ended December 31, 1997.     
 
                                          Price Waterhouse LLP
 
Chicago, Illinois
   
May 22, 1998